Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets
Joint Authors
Onishi, Anne C.
Lee, Francis Youngin
Hincker, Alexander M.
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-11-29
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Chondrosarcoma, a primary malignancy of bone, has eluded successful treatment with modern chemotherapeutic and radiation regimens.
To date, surgical resection of these tumors remains the only curative treatment offered to patients with this diagnosis.
Understanding and exploring the nature of chemotherapy and radiation resistance in chondrosarcoma could lead to new molecular targets and more directed therapy for these notoriously difficult-to-treat tumors.
Here we review the most current hypotheses regarding the molecular mechanisms mediating chemotherapy and radiation resistance and the future direction of chondrosarcoma therapy research.
American Psychological Association (APA)
Onishi, Anne C.& Hincker, Alexander M.& Lee, Francis Youngin. 2010. Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets. Complexity،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-991169
Modern Language Association (MLA)
Onishi, Anne C.…[et al.]. Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets. Complexity No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-991169
American Medical Association (AMA)
Onishi, Anne C.& Hincker, Alexander M.& Lee, Francis Youngin. Surmounting Chemotherapy and Radioresistance in Chondrosarcoma: Molecular Mechanisms and Therapeutic Targets. Complexity. 2010. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-991169
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-991169